Marken "direct patient" delivery service market demand trends

The latest data show, medical logistics company Marken launched in 2012 by the end of the "direct patient" door-to-door delivery service, in recent years in clinical trials of market demand.
"The launch of direct patient" service, through a distribution method of convenient, patients into groups to help pharmaceutical companies and contract research institutions to increase clinical trials. Because of the "direct patient" services for the pharmaceutical industry provides a new channel for recruitment and retention of patients. Therefore, the service market demand grow with each passing day.
Marken provides a "direct patient" service, clinical trial material can be directly sent to the patient's home, effectively improve the patient's participation and enthusiasm, so that patients can need not consider the research institutions of distance. If the pharmaceutical enterprises to consider the use of "direct patient" service to carry out clinical trials, the Marken is responsible for the feasibility analysis in each country to provide this service.
Marken company relevant responsible person said, at the launch of "direct patient" service 1 years ago, the company in more than 20 countries launched the service demand survey. For pharmaceutical enterprises, can have a logistics provider security services, attract more patients in the group of test, improve patient engagement is key to open up the market.
MYEX Minya Express International
2013-08-28